Treace Medical Concepts/TMCI

$11.11

0.09%
-
1D1W1MYTD1YMAX

About Treace Medical Concepts

Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.

Ticker

TMCI

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

John Treace

Employees

516

Headquarters

Ponte vedra, United States

TMCI Metrics

BasicAdvanced
$679.44M
Market cap
-
P/E ratio
-$0.82
EPS
-
Beta
-
Dividend rate
$679.44M
$27.70
$5.27
412.69K
4.405
3.755
38.429
38.429
-24.1%
-49.91%
-29.51%
3.631
4.911
5.852
31.92%
-5.25%
48.31%

What the Analysts think about TMCI

Analyst Ratings

Majority rating from 7 analysts.
Buy

Price Targets

Average projection from 7 analysts.
42.75% upside
High $18.00
Low $14.00
$11.11
Current price
$15.86
Average price target

TMCI Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-9.96% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$62.2M
52.83%
Net income
$-6.2M
-64.57%
Profit margin
-9.96%
-76.83%

TMCI Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 12.9%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.23
-$0.20
-$0.28
-$0.10
-
Expected
-$0.23
-$0.24
-$0.26
-$0.09
-$0.30
Surprise
0.73%
-16.08%
7.1%
12.9%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Treace Medical Concepts stock?

Treace Medical Concepts (TMCI) has a market cap of $679.44M as of April 23, 2024.

What is the P/E ratio for Treace Medical Concepts stock?

The price to earnings (P/E) ratio for Treace Medical Concepts (TMCI) stock is 0 as of April 23, 2024.

Does Treace Medical Concepts stock pay dividends?

No, Treace Medical Concepts (TMCI) stock does not pay dividends to its shareholders as of April 23, 2024.

When is the next Treace Medical Concepts dividend payment date?

Treace Medical Concepts (TMCI) stock does not pay dividends to its shareholders.

What is the beta indicator for Treace Medical Concepts?

Treace Medical Concepts (TMCI) does not currently have a Beta indicator.

What is the Treace Medical Concepts stock price target?

The target price for Treace Medical Concepts (TMCI) stock is $15.86, which is 42.75% above the current price of $11.11. This is an average based on projections from 7 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Treace Medical Concepts stock

Buy or sell Treace Medical Concepts stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing